Mitsubishi Tanabe Pharma Corporation - Financial and Strategic Analysis Review

Summary

Mitsubishi Tanabe Pharma Corporation - Financial and Strategic Analysis Review

Summary

Mitsubishi Tanabe Pharma Corporation (Mitsubishi Tanabe) is a Japan-based pharmaceutical company engaged in the manufacturing and marketing of pharmaceutical products. The company is formed through the merger of Tanabe Seiyaku Co., Ltd., and Mitsubishi Pharma Corporation. It offers several cardiovascular drugs, biological products, central nervous system drugs, gastroenterology drugs, allergy/respiratory drugs and digestive medicines. The company is headquartered in Chuo-ku, Osaka, Japan. In February 2009, the company entered into an agreement with GlaxoSmithKline to co-promote Adoair, a combination drug for the treat asthma.

Global Markets Direct's Mitsubishi Tanabe Pharma Corporation - Financial and Strategic Analysis Review is an in-depth business, strategic and financial analysis of Mitsubishi Tanabe Pharma Corporation. The report provides a comprehensive insight into the company, including business structure and operations, executive biographies and key competitors. The hallmark of the report is the detailed strategic analysis of the company. This highlights its strengths and weaknesses and the opportunities and threats it faces going forward.

Scope

• Provides key company information for business intelligence needs.
• The company's strengths and weaknesses and areas of development or decline are analyzed. Financial, strategic and operational factors are considered.
• The opportunities open to the company are considered and its growth potential assessed. Competitive or technological threats are highlighted.
• The report contains critical company information - business structure and operations, the company history, major products and services, key competitors, key employees and executive biographies, different locations and important subsidiaries.
• The report provides detailed financial ratios for the past five years as well as interim ratios for the last four quarters.
• Financial ratios include profitability, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Reasons to buy

• A quick "one-stop-shop" to understand the company.
• Enhance business/sales activities by understanding customers' businesses better.
• Get detailed information and financial and strategic analysis on companies operating in your industry.
• Identify prospective partners and suppliers - with key data on their businesses and locations.
• Capitalize on competitor's weaknesses and target the market opportunities available to them.
• Compare your company's financial trends with those of your peers / competitors.
• Scout for potential acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

Contents

• List of Tables
• List of Figures
  • Mitsubishi Tanabe Pharma Corporation - Key Facts
  • Mitsubishi Tanabe Pharma Corporation - Business Description
  • Mitsubishi Tanabe Pharma Corporation - Major Products and Services
  • Mitsubishi Tanabe Pharma Corporation - History
  • Mitsubishi Tanabe Pharma Corporation - SWOT Analysis
  • SWOT Analysis - Overview
  • Mitsubishi Tanabe Pharma Corporation - Strengths
  • Strength - Significant Increase in Revenues
  • Strength - Wide Array of Products
  • Strength - Sturdy Research and Development Activities
  • Strength - Strong Liquidity Position
  • Mitsubishi Tanabe Pharma Corporation - Weaknesses
  • Weakness - Withdrawal of Medway Injection 5% and 25%
  • Weakness - HCV Litigation
  • Weakness - Declining Operating Margin
  • Mitsubishi Tanabe Pharma Corporation - Opportunities
  • Opportunity - License Agreement with EnVivo Pharmaceuticals
  • Opportunity - New Structure
  • Opportunity - Pipeline Products
  • Opportunity - Focus on Generic Operations
  • Opportunity - Emerging Markets
  • Mitsubishi Tanabe Pharma Corporation - Threats
  • Threat - Changes in Regulations
  • Threat - Product Defects
  • Threat - Emergence of Biogenerics / Biosimilars
  • Threat - Impact of the Financial Crisis
  • Threat - Uncertainties in R&D
  • Mitsubishi Tanabe Pharma Corporation - Key Competitors
  • Mitsubishi Tanabe Pharma Corporation - Key Employees
  • Mitsubishi Tanabe Pharma Corporation - Company Statement
  • Mitsubishi Tanabe Pharma Corporation - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
  • Mitsubishi Tanabe Pharma Corporation - Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
  • Appendix
  • Methodology
  • Ratio Definitions
  • About Global Markets Direct
  • Contact Us
  • Disclaimer
• List of Tables
  • Mitsubishi Tanabe Pharma Corporation, Key Facts
  • Mitsubishi Tanabe Pharma Corporation, Major Products and Services
  • Mitsubishi Tanabe Pharma Corporation, History
  • Mitsubishi Tanabe Pharma Corporation, Key Employees
  • Mitsubishi Tanabe Pharma Corporation, Other Locations
  • Mitsubishi Tanabe Pharma Corporation, Ratios based on current share price
  • Mitsubishi Tanabe Pharma Corporation, Annual Ratios
  • Mitsubishi Tanabe Pharma Corporation, Interim Ratios
• List of Figures
  • Mitsubishi Tanabe Pharma Corporation, Ratio Charts